Mudzviti, Tinashe, et al. “Implementing a Pharmacovigilance Program to Evaluate Cutaneous Adverse Drug Reactions in an Antiretroviral Access Program”. The Journal of Infection in Developing Countries, vol. 6, no. 11, Nov. 2012, pp. 806-8, doi:10.3855/jidc.1908.